NYSE:NSPR

InspireMD (NSPR) Stock Price, News & Analysis

$1.91
-0.18 (-8.61%)
(As of 04/22/2024 ET)
Today's Range
$1.87
$2.14
50-Day Range
$1.91
$2.79
52-Week Range
$1.00
$3.85
Volume
21,334 shs
Average Volume
66,966 shs
Market Capitalization
$44.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.85

InspireMD MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
153.9% Upside
$4.85 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.61) to ($0.50) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.03 out of 5 stars

Medical Sector

508th out of 910 stocks

Surgical & Medical Instruments Industry

59th out of 97 stocks

NSPR stock logo

About InspireMD Stock (NYSE:NSPR)

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

NSPR Stock Price History

NSPR Stock News Headlines

InspireMD (NYSE:NSPR) Now Covered by Analysts at StockNews.com
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Preview: InspireMD's Earnings
NSPR Mar 2024 7.500 call
InspireMD earnings: here's what Wall Street expects
InspireMD Q3 2023 Earnings Preview
Piper Sandler Remains a Buy on InspireMD (NSPR)
See More Headlines
Receive NSPR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InspireMD and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/06/2024
Today
4/23/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Fax
N/A
Employees
65
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$4.85
High Stock Price Target
$5.20
Low Stock Price Target
$4.50
Potential Upside/Downside
+153.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-19,920,000.00
Net Margins
-320.97%
Pretax Margin
-319.92%

Debt

Sales & Book Value

Annual Sales
$6.20 million
Book Value
$1.83 per share

Miscellaneous

Free Float
18,342,000
Market Cap
$44.69 million
Optionable
Optionable
Beta
0.84
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Mr. Marvin L. Slosman (Age 60)
    President, CEO & Director
    Comp: $696.81k
  • Mr. Craig Shore (Age 63)
    CFO, Chief Administrative Officer, Secretary & Treasurer
    Comp: $625.24k
  • Mr. Andrea Tommasoli (Age 52)
    Chief Operating Officer
    Comp: $359.27k
  • Mr. Amir Kohen
    Vice President of Finance & Human Resources
  • Mr. Shane Thomas Gleason (Age 49)
    Chief Commercial Officer
  • Dr. Patrick A. Verta DVM (Age 66)
    M.D., MS Stat, Executive Vice President of Clinical & Medical Affairs
  • Mr. Pete Ligotti
    Executive VP & GM of North America
  • Dr. Sol J. Barer Ph.D. (Age 77)
    Special Advisor to the Board
    Comp: $13.92k

NSPR Stock Analysis - Frequently Asked Questions

Should I buy or sell InspireMD stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" NSPR shares.
View NSPR analyst ratings
or view top-rated stocks.

What is InspireMD's stock price target for 2024?

1 analysts have issued 1 year price objectives for InspireMD's stock. Their NSPR share price targets range from $4.50 to $5.20. On average, they predict the company's stock price to reach $4.85 in the next year. This suggests a possible upside of 153.9% from the stock's current price.
View analysts price targets for NSPR
or view top-rated stocks among Wall Street analysts.

How have NSPR shares performed in 2024?

InspireMD's stock was trading at $2.81 at the beginning of the year. Since then, NSPR stock has decreased by 32.0% and is now trading at $1.91.
View the best growth stocks for 2024 here
.

When is InspireMD's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our NSPR earnings forecast
.

How were InspireMD's earnings last quarter?

InspireMD, Inc. (NYSE:NSPR) issued its earnings results on Wednesday, March, 6th. The company reported ($0.16) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.04. The company earned $1.76 million during the quarter, compared to analyst estimates of $1.65 million. InspireMD had a negative trailing twelve-month return on equity of 55.71% and a negative net margin of 320.97%. During the same period in the previous year, the firm earned ($0.60) earnings per share.

What other stocks do shareholders of InspireMD own?
How do I buy shares of InspireMD?

Shares of NSPR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:NSPR) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners